Chamber and committees

This information is not held centrally. It is the responsibility of territorial Health Boards to ensure there is adequate provision of NHS Pharmaceutical Care Services, working with community pharmacy contractors listed on the Boards Pharmaceutical List.

The National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009 set out the responsibilities for community pharmacy contractors to notify Health Boards when there are instances in which the contractor is unable to provide those NHS services.

Please note that data regarding the number of COVID-19 vaccination sessions delivered are held by individual NHS Health Boards.

The information requested is not held centrally. Details of the funding awarded to the Scottish Environment Protection Agency (SEPA) and the Royal Botanic Garden Edinburgh is published in annual reports and accounts available at www.sepa.org.uk and www.rbge.org.uk . Details of Scottish Government funding provided to Scotland’s Rural College (SRUC) are published in their Annual Financial statements available on their website at www.sruc.ac.uk .

Budget allocations to areas of the Scottish Government are published in annual Draft Budget documents available on the Scottish Government’s website at www.gov.scot .

The Turing Scheme is currently signposted on the Scottish Government mygov.scot public services website, as well as on the website for the Scottish Funding Council.

Any action to promote the Turing Scheme will be for local authorities themselves to decide and report on.

It is the Scottish Government’s position that the UK Government’s Turing Scheme is not fit for purpose. It is a replacement scheme, which cannot match the breadth and scope of Erasmus+. With funding only guaranteed for one year, no provision for inward mobility to the UK, and no support being offered for adult education and youth work, Turing will see support for our most disadvantaged learners cut, and opportunities for our students, staff and young people reduced.

We will continue to engage with the UK Government to ensure Turing better reflect the needs of Scotland.

Rollout of mobile telecommunications infrastructure is predominantly led by commercial operators. The Scottish Government neither holds nor receives data on how many commercial mobile telephony masts have been installed..

Through the Scottish 4G Infill (S4GI) Programme, the Scottish Government is investing £28.75 million (including £11.27 million of ERDF funding) to create future-proofed 4G mobile infrastructure at up to 55 mobile “notspots”, areas with no coverage from any commercial mobile network operator (MNO).

As of 28 June 2021, a total of 15 S4GI masts are currently providing 4G service to communities is as follows:

Flood Risk Management Strategies were published by SEPA in 2015. These set out proposals for 42 flood protection schemes which were prioritised according to their cost benefit ratio and taking into account a series of additional criteria, encompassing the environmental and social impacts of flooding.

It is for local authorities to commission and take forward these Schemes. In July 2016, it was agreed by Scottish Ministers and COSLA that 80% of the flood component of the General Capital Grant would be distributed according to the SEPA prioritisation of flood protection schemes set out in the Flood Risk Management Strategies. 40 of the prioritised schemes were deemed to be eligible for grant funding.

Of the 42 prioritised schemes 9 are complete, 5 are under construction and the others are at various stages of development. 7 other schemes commissioned by local authorities prior to 2016 have also been completed since 2016.

The Complex Pelvic Mesh Removal Service in NHS Greater Glasgow and Clyde (NHS GGC) is managed through a Service Level Agreement with NHS National Services Scotland (NSS). The service reports to NSS on a number of indicators, including patient experience data, any significant adverse events and waiting times. This information will be used for comparison across the UK specialist centres, and will support quality assurance and improvement.

In addition, NHS Scotland is taking part in the development of a UK-wide Pelvic Floor Registry, which will aim to monitor and improve patient safety. It will record surgical mesh implants, and related medical devices, given to patients, and the organisations and surgeons that have carried out the procedures.

The registry will also collect information about patients that receive alternative procedures that do not include a medical device or implant so that outcomes can be compared and complications can be understood.

The main aim of the registry is to improve patient safety. It will mean that patients can be traced in the event of a product recall or safety concern relating to a specific type of implant or treatment. Outcomes data collected by the registry will also be used to improve procedures offered to future patients.

NHS Scotland will pilot the registry in Scotland and the NHS GGC will be involved.

I refer the member to the answer to question S6W-00790 on‎ 13 July 2021. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

A breakdown of these awards by local authority area is not currently gathered although this information is collected at application entry level and is as follows:

The Scottish Government is aware of the vast challenges in attempting to ensure pancreatic enzyme replacement therapy is offered to every patient at the point of diagnosis.

Pancreatic cancer patients can present as asymptomatic despite pancreatic exocrine insufficiency, while patients can also be diagnosed through many different pathways.

This can result in clinicians not always having the specialist knowledge and experience to know about the importance of pancreatic enzyme replacement therapy.

The Scottish Governments National Cancer Recovery Plan will help address this knowledge gap by working to review Cancer Clinical Management Guidelines in liaison with relevant parties.

Under the National Cancer Recovery Plan, we have funded the Scottish HepatoPancreatoBiliary Cancer Network (SHPBN) which is reviewing guidelines to address this issue.